Dr. Sina Habibi the CEO and Founder of Cognetivity Neurosciences presents his company to our Proactive audience.
Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimer's disease.
Habibi says their technology is '5-10 times faster and cheaper than existing solutions' in the market for addressing these cognitive diseases.
The company's patented rapid cognitive analysis technology aims to make early detection a reality, and aims to bring the benefits of being: easier to administer, more accessible, less expensive, allowing earlier and more accurate diagnosis.